Thoratec Corp (NASDAQ:THOR)

CAPS Rating: 3 out of 5

The Company manufactures, develops and markets medical devices used for circulatory support.


Player Avatar nemaline (91.96) Submitted: 10/18/2006 10:29:01 AM : Outperform Start Price: $15.70 THOR Score: +2.85

With the advent of the Heartmate II device, this company has the opportunity to win big in the left ventricular assist device category with a solid product offering. Although awaiting approval from the FDA, the company has the happy misfortune of being popular. The popularity of this device, in contrast to former devices, suggests that this one is a real winner. Thoratec in 2007!

Member Avatar nemaline (91.96) Submitted: 1/5/2007 2:30:09 PM
Recs: 0

Medicare is going to expand its coverage. This may result in DOUBLING of utilization of HM II devices! We'll know in April of 2007.

Featured Broker Partners